ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

SLN Silence Therapeutics PLC

21.21
-1.74 (-7.58%)
11 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Silence Therapeutics PLC SLN 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-1.74 -7.58% 21.21 09:00:00
개장가 저가 고가 종가 전일 종가
22.84 21.23 23.09 21.21 22.95
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
09/05/202406:14EDGAR2Form DEL AM - Delaying amendment
30/04/202421:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29/04/202421:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
09/04/202400:48BWSilence Therapeutics Announces JAMA Publication of..
13/03/202420:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13/03/202420:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13/03/202420:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
28/02/202422:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
23/02/202422:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/02/202422:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
14/02/202423:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/02/202422:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31/01/202421:00BWSilence Therapeutics to Participate in Fireside Chat at..
01/12/202321:00BWSilence Therapeutics Strengthens Executive Leadership Team..
14/11/202321:00BWSilence Therapeutics Highlights Recent Company Progress and..
08/11/202321:00BWSilence Therapeutics to Present at Jefferies London..
01/11/202320:00BWSilence Therapeutics Announces Positive Topline Results from..
26/09/202320:00BWSilence Therapeutics to Participate in Fireside Chat at..
06/09/202320:00BWSilence Therapeutics to Participate in September Investor..
30/08/202305:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/08/202320:00BWSilence Therapeutics Reports Second Quarter 2023 Results
02/08/202305:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/07/202320:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202320:00BWSilence Therapeutics Achieves $4 Million in Research..
31/05/202320:00BWSilence Therapeutics to Present at the Jefferies Healthcare..
17/05/202305:00BWSilence Therapeutics Reports First Quarter 2023 Results